<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://hormonejournal.com/news/glp-1-drugs-canadian-children-pediatric-obesity-safety-data</loc>
    <news:news>
      <news:publication>
        <news:name>Hormone Journal</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-02T00:00:00.000Z</news:publication_date>
      <news:title>GLP-1 drugs in Canadian children: what emerging safety data means for pediatric obesity care</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://hormonejournal.com/news/oral-wegovy-semaglutide-pill-weight-loss-real-world-canada-glp1</loc>
    <news:news>
      <news:publication>
        <news:name>Hormone Journal</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-01T00:00:00.000Z</news:publication_date>
      <news:title>Novo Nordisk&apos;s oral semaglutide (Wegovy pill) shows greater weight loss than injections in real-world data: what does it mean for Canadian GLP-1 patients?</news:title>
    </news:news>
  </url>
</urlset>